Pharmacological Treatment of Inflammatory Bowel Disease
Sorry, this course has expired and is no longer available.
IBD or IBS? UC or CD? Understanding the differences between these acronyms and their associated disease characteristics is important when it comes to determining pharmacological treatment for these conditions. There are many comprehensive resources that can be used to guide treatment for bowel diseases, so join Dr Jenny Gowan for a review of these guidelines and a refresher on common bowel conditions.
Jenny is a practicing pharmacist, a Teaching Associate at Monash University and Clinical Associate at RMIT university . She is a current member of the PSA Branch committee, Editorial Board Member of AUS-DI (Drug information), Guidelines Committee for the National Asthma Council Australian Asthma Handbook, and RACGP Silver book for Aged Care .
Jenny is an accredited consultant pharmacist, and conducts her own company focussing on medication reviews in the home and Aged Care Facilities as well as Quality Use of Medicine consultancy. She works regularly in community pharmacy plus sessions in a GP clinic at a Community Health Centre. Jenny has published over 380 educational articles and presents hundreds of talks annually.
In 2010 Jenny received the Sanofi-Aventis award by the University of Sydney, in 2013, PSA Australian Pharmacist of the Year and 2016 Jenny was the AACP-MIMs Consultant Pharmacist of the Year. See Educator Profile